Literature DB >> 32347526

Reproducible Quantification of Regional Sympathetic Denervation with [11C]meta-Hydroxyephedrine PET Imaging.

Jean Z Wang1,2, Jonathan B Moody3, Nicole Kaps1, Deron Britt1,2, Aaryn Lavallee1, Jennifer M Renaud1,3, Jason G E Zelt1,2,4, Kai Yi Wu1,2, Rob S Beanlands1,2,4, James A Fallavollita5,6, John M Canty5,6, Robert A deKemp7.   

Abstract

BACKGROUND: Regional cardiac sympathetic denervation is predictive of sudden cardiac arrest in patients with ischemic cardiomyopathy. The reproducibility of denervation scores between automated software programs has not been evaluated. This study seeks to (1) compare the inter-rater reliability of regional denervation measurements using two analysis programs: FlowQuant® and Corridor4DM®; (2) evaluate test-retest repeatability of regional denervation scores.
METHODS: N = 190 dynamic [11C]meta-hydroxyephedrine (HED) PET scans were reviewed from the PAREPET trial in ischemic cardiomyopathy patients with reduced left ventricular ejection fraction(LVEF ≤ 35%). N = 12 scans were excluded due to non-diagnostic quality. N = 178 scans were analyzed using FlowQuant and Corridor4DM software, each by two observers. Test-retest scans from N = 20 patients with stable heart failure were utilized for test-retest analysis. Denervation scores were defined as extent × severity of relative uptake defects in LV regions with < 75% of maximal uptake. Results were evaluated using intraclass correlation coefficient (ICC) and Bland-Altman coefficient of repeatability (RPC).
RESULTS: Inter-observer, inter-software, and test-retest ICC values were excellent (ICC = 94% to 99%) and measurement variability was small (RPC < 11%). Mean differences between observers ranged .2% to 1.1% for Corridor4DM (P = .28), FlowQuant (P < .001), and between software programs (P < .001). Kaplan-Meier analysis demonstrated HED scores from both programs were predictive of SCA.
CONCLUSION: Inter-rater reliability for both analysis programs was excellent and test-retest repeatability was consistent. The minimal difference in scores between FlowQuant and Corridor4DM supports their use in future trials.
© 2020. American Society of Nuclear Cardiology.

Entities:  

Keywords:  PET; cardiac innervation; innervation tracers

Mesh:

Substances:

Year:  2020        PMID: 32347526      PMCID: PMC7673573          DOI: 10.1007/s12350-020-02114-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  3 in total

1.  Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging.

Authors:  K C Rosenspire; M S Haka; M E Van Dort; D M Jewett; D L Gildersleeve; M Schwaiger; D M Wieland
Journal:  J Nucl Med       Date:  1990-08       Impact factor: 10.057

Review 2.  Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure.

Authors:  Jason G E Zelt; Robert A deKemp; Benjamin H Rotstein; Girish M Nair; Jagat Narula; Ali Ahmadi; Rob S Beanlands; Lisa M Mielniczuk
Journal:  JACC Cardiovasc Imaging       Date:  2019-07-17

3.  Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.

Authors:  James A Fallavollita; Jonathan D Dare; Randolph L Carter; Sunil Baldwa; John M Canty
Journal:  Circ Cardiovasc Imaging       Date:  2017-08       Impact factor: 7.792

  3 in total
  2 in total

1.  Positron Emission Tomography Imaging of Regional Versus Global Myocardial Sympathetic Activity to Improve Risk Stratification in Patients With Ischemic Cardiomyopathy.

Authors:  Jason G E Zelt; Jean Zhuo Wang; Lisa M Mielniczuk; Rob S B Beanlands; James A Fallavollita; John M Canty; Robert A deKemp
Journal:  Circ Cardiovasc Imaging       Date:  2021-06-09       Impact factor: 8.589

2.  Does quantification of [11C]meta-hydroxyephedrine and [13N]ammonia kinetics improve risk stratification in ischemic cardiomyopathy.

Authors:  Jean Z Wang; Jason G E Zelt; Nicole Kaps; Aaryn Lavallee; Jennifer M Renaud; Benjamin Rotstein; Rob S B Beanlands; James A Fallavollita; John M Canty; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2021-08-02       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.